Suivre
Ruben Smith
Ruben Smith
Adresse e-mail validée de med.lu.se
Titre
Citée par
Citée par
Année
Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
S Janelidze, N Mattsson, S Palmqvist, R Smith, TG Beach, GE Serrano, ...
Nature medicine 26 (3), 379-386, 2020
7942020
Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders
S Palmqvist, S Janelidze, YT Quiroz, H Zetterberg, F Lopera, E Stomrud, ...
Jama 324 (8), 772-781, 2020
7702020
Four distinct trajectories of tau deposition identified in Alzheimer’s disease
JW Vogel, AL Young, NP Oxtoby, R Smith, R Ossenkoppele, ...
Nature medicine 27 (5), 871-881, 2021
4102021
Discriminative accuracy of [18F] flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders
R Ossenkoppele, GD Rabinovici, R Smith, H Cho, M Schöll, O Strandberg, ...
Jama 320 (11), 1151-1162, 2018
3532018
Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
JW Vogel, Y Iturria-Medina, OT Strandberg, R Smith, E Levitis, AC Evans, ...
Nature communications 11 (1), 2612, 2020
3392020
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
S Palmqvist, H Zetterberg, N Mattsson, P Johansson, ...
Neurology 85 (14), 1240-1249, 2015
3282015
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
S Janelidze, E Stomrud, R Smith, S Palmqvist, N Mattsson, DC Airey, ...
Nature communications 11 (1), 1683, 2020
3092020
Orexin loss in Huntington's disease
Å Petersén, J Gil, MLC Maat-Schieman, M Björkqvist, H Tanila, IM Araujo, ...
Human molecular genetics 14 (1), 39-47, 2005
3072005
Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease
R Ossenkoppele, R Smith, T Ohlsson, O Strandberg, N Mattsson, PS Insel, ...
Neurology 92 (6), e601-e612, 2019
2342019
Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease
N Mattsson-Carlgren, E Andersson, S Janelidze, R Ossenkoppele, P Insel, ...
Science advances 6 (16), eaaz2387, 2020
2302020
Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease
JB Pereira, S Janelidze, R Smith, N Mattsson-Carlgren, S Palmqvist, ...
Brain 144 (11), 3505-3516, 2021
2292021
Synaptic dysfunction in Huntington’s disease: a new perspective
R Smith, P Brundin, JY Li
Cellular and Molecular Life Sciences CMLS 62, 1901-1912, 2005
2232005
Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease
N Franzmeier, J Neitzel, A Rubinski, R Smith, O Strandberg, ...
Nature communications 11 (1), 347, 2020
2212020
Associations of plasma phospho-tau217 levels with tau positron emission tomography in early Alzheimer disease
S Janelidze, D Berron, R Smith, O Strandberg, NK Proctor, JL Dage, ...
JAMA neurology 78 (2), 149-156, 2021
2082021
18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease
N Mattsson, M Schöll, O Strandberg, R Smith, S Palmqvist, PS Insel, ...
EMBO molecular medicine 9 (9), 1212-1223, 2017
1932017
18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers
R Smith, A Puschmann, M Schöll, T Ohlsson, J Van Swieten, M Honer, ...
Brain 139 (9), 2372-2379, 2016
1822016
Accuracy of tau positron emission tomography as a prognostic marker in preclinical and prodromal Alzheimer disease: a head-to-head comparison against amyloid positron emission …
R Ossenkoppele, R Smith, N Mattsson-Carlgren, C Groot, A Leuzy, ...
JAMA neurology 78 (8), 961-971, 2021
1632021
Increased metabolism in the R6/2 mouse model of Huntington’s disease
JMM van der Burg, K Bacos, NI Wood, A Lindqvist, N Wierup, B Woodman, ...
Neurobiology of disease 29 (1), 41-51, 2008
1542008
Diagnostic performance of RO948 F 18 tau positron emission tomography in the differentiation of Alzheimer disease from other neurodegenerative disorders
A Leuzy, R Smith, R Ossenkoppele, A Santillo, E Borroni, G Klein, ...
JAMA neurology 77 (8), 955-965, 2020
1532020
Cholinergic neuronal defect without cell loss in Huntington's disease
R Smith, H Chung, S Rundquist, MLC Maat-Schieman, L Colgan, ...
Human molecular genetics 15 (21), 3119-3131, 2006
1502006
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20